8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 8, 2008

SRS LABS, INC.

(Exact Name of registrant as specified in its charter)

Delaware	0-21123	33-0714264
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)
2909 Daimler Street Santa Ana, California		92705
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (949) 442-1070

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02.              Results of Operation and Financial Condition.

The information being furnished in this Item 2.02 and in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

On May 8, 2008, SRS Labs, Inc. issued a press release announcing its operating results for the first quarter 2008. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 9.01.              Financial Statements and Exhibits.

Exhibit No.	Description
99.1	Press Release dated May 8, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SRS LABS, INC.,
	a Delaware corporation
Date: May 8, 2008
	By:	/S/ THOMAS C.K. YUEN
		Thomas C.K. Yuen
		Chairman of the Board and
		Chief Executive Officer

2

EX-99.1

Exhibit 99.1

FOR IMMEDIATE RELEASE

Investor Contact:

Ulrich Gottschling

Chief Financial Officer

(949) 442-5596

ir@srslabs.com

SRS LABS REPORTS RESULTS FOR FIRST QUARTER 2008

Santa Ana, Calif., May 8, 2008 - SRS Labs, Inc. (NASDAQ: SRSL), the industry leader in surround sound, audio and voice technologies, announced today revenues for the three months ended March 31, 2008 of $4.9 million, as compared to $5.1 million for the same period in the prior year. Net income for the three months ended March 31, 2008 was $858 thousand, or $0.05 per diluted share, as compared to $1.4 million, or $0.08 per diluted share, for the same period in the prior year.

Thomas C.K. Yuen, Chairman and CEO of SRS Labs, Inc., commented on the results of the Company’s activities:

“As discussed in last quarter’s earnings release, SRS is placing significant emphasis on hiring, development and licensing activities in order to provide an even more solid foundation for revenue growth. We are pleased with the initial results of these activities during the first quarter and believe that positive results will be experienced during future quarters.

In particular, the response to our two latest technologies, SRS VolumeIQ™ (volume control) and  SRS CS Headphone™ (surround sound), has been very promising and we are excited about their potential. We believe that these technologies have excellent applicability to many of our markets, including the television, set top box and mobile markets and we look forward to announcing design win activities in the near future. We are pleased to be working with many of the best global consumer electronics companies and look forward to continuing to provide best in class technologies and services.”

Conference Call

SRS Labs will host a conference call and webcast at 2 p.m. Pacific Time today (5 p.m. Eastern Time) to review its first quarter 2008 results. The dial-in number for the call is (866) 253-6509; ask for “SRS Labs Q1 2008 Financial Results Conference Call.”  An audio replay of the conference call will be available until May 15, 2008 at 6:00 p.m. Pacific Time via telephone.  The audio replay dial-in number is 866-837-8032, enter access code 1203344.

Investors can listen to the conference call live online by accessing the link on the main page of the Investor sections of the SRS Labs website or by using this link: http://www.srswowcast.com/about_us/wmptechlog.asp?lnkID=118

Please log on at least 15 minutes early to register and follow the instructions.

The webcast will be archived on www.srslabs.com for 60 days following the call.

About SRS Labs, Inc.

Founded in 1993, SRS Labs is the industry leader in audio signal processing for consumer electronics. Initially based on audio technologies developed at Hughes Aircraft, SRS Labs now holds over 150 worldwide patents and is recognized by the industry as the foremost authority in research and application of human auditory principles. Through partnerships with leading global Consumer Electronics companies, semiconductor manufacturers and software partners, SRS audio, surround sound and voice processing technologies have been included in over one billion electronic products sold worldwide including HDTVs, mobile phones, portable media devices, PCs and automotive entertainment. In fact, SRS Labs is the defacto standard of HDTV audio processing with nine of the top ten name brand flat panel TVs

featuring SRS technology. Additionally, SRS Labs’ surround sound solutions provide the professional broadcast and recording industries with high-performance production, back-haul, storage, and transmission capability. SRS Labs supports manufacturers worldwide with offices in the US, China, Europe, Japan, Korea and Taiwan. For more information, visit www.srslabs.com.

Except for historical information contained in this release, all statements in this release, including those of Mr. Yuen, are forward-looking statements that are based on management’s beliefs, as well as assumptions made by, and information currently available to management.  While the Company believes that its expectations are based upon reasonable assumptions, there can be no assurances that the Company’s goals and strategy will be realized. Numerous factors, including risks and uncertainties, may affect the Company’s actual results and may cause results to differ materially from those expressed in or implied by forward-looking statements made by or on behalf of the Company. These factors include, but are not limited to, the acceptance of new SRS Labs’ products and technologies, the impact of competitive products and pricing, the timely development and release of technologies by the Company, general business and economic conditions, especially in Asia, and other factors detailed in the Company’s Form 10-K and other periodic reports filed with the SEC.  SRS Labs specifically disclaims any obligation to update or revise any forward-looking statement whether as a result of new information, future developments or otherwise.

– More –

SRS Labs, Inc., 2909 Daimler Street, Santa Ana, CA  92705    Tel 949-442-1070

Fax 949-852-1099   www.srslabs.com

SRS LABS, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED BALANCE SHEETS

	March 31, 2008			December 31, 2007
	(unaudited)
ASSETS
Current Assets
Cash and cash equivalents	$	47,687,989		$	39,615,291
Accounts receivable, net	384,485			1,138,425
Prepaid expenses and other current assets	1,010,355			893,388
Total Current Assets	49,082,829			41,647,104
Investments available for sale	—			5,451,875
Property and equipment, net	351,726			309,727
Intangible assets, net	2,280,932			2,197,616
Deferred income taxes, net	2,239,276			1,776,202
Total Assets	$	53,954,763		$	51,382,524
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Accounts payable	$	453,247		$	529,063
Accrued liabilities	796,977			689,308
Deferred revenue	2,312,050			1,156,836
Total Current Liabilities	3,562,274			2,375,207
Commitments and Contingencies
Stockholders’ Equity
Preferred stock—$.001 par value; 2,000,000 shares authorized; no shares issued or outstanding	—			—
Common stock—$.001 par value; 56,000,000 shares authorized; 16,946,377 shares issued; and 15,773,715 and 15,778,715 shares outstanding at March 31, 2008 and December 31, 2007, respectively	16,947			16,947
Additional paid-in capital	74,646,916			74,143,772
Accumulated other comprehensive loss	—			(48,125		)
Accumulated deficit	(18,296,744		)	(19,155,096		)
Treasury stock at cost, 1,172,662 and 1,167,662 shares at March 31, 2008 and December 31, 2007, respectively	(5,974,630		)	(5,950,181		)
Total Stockholders’ Equity	50,392,489			49,007,317
Total Liabilities and Stockholders’ Equity	$	53,954,763		$	51,382,524

SRS LABS, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended  March 31,
	2008			2007
Revenues	$	4,940,988		$	5,072,403
Cost of sales	25,949			38,540
Gross profit	4,915,039			5,033,863
Operating expenses:
Sales and marketing	2,143,622			1,876,293
Research and development	926,762			861,625
General and administrative	1,438,358			1,377,427
Total operating expenses	4,508,742			4,115,345
Operating income	406,297			918,518
Other income, net	449,961			493,796
Income before income taxes	856,258			1,412,314
Income taxes	(2,094		)	—
Net income	$	858,352		$	1,412,314
Net income per common share:
Basic	$	0.05		$	0.09
Diluted	$	0.05		$	0.08
Weighted average shares used in the per share calculation:
Basic	15,778,188			15,992,704
Diluted	16,305,095			17,081,524